These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 35956991)

  • 1. The Potential of Lamiaceae Herbs for Mitigation of Overweight, Obesity, and Fatty Liver: Studies and Perspectives.
    Diab F; Zbeeb H; Baldini F; Portincasa P; Khalil M; Vergani L
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose and non-adipose perspectives of plant derived natural compounds for mitigation of obesity.
    Borah AK; Sharma P; Singh A; Kalita KJ; Saha S; Chandra Borah J
    J Ethnopharmacol; 2021 Nov; 280():114410. PubMed ID: 34273447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease.
    Liu Q; Zhu L; Cheng C; Hu YY; Feng Q
    Curr Pharm Des; 2017; 23(34):5136-5162. PubMed ID: 28925892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review.
    Bagherniya M; Nobili V; Blesso CN; Sahebkar A
    Pharmacol Res; 2018 Apr; 130():213-240. PubMed ID: 29287685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
    Wat E; Wang Y; Chan K; Law HW; Koon CM; Lau KM; Leung PC; Yan C; Lau CBS
    Phytomedicine; 2018 Mar; 42():112-125. PubMed ID: 29655677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisteatotic and antioxidant activities of Thymbra spicata L. extracts in hepatic and endothelial cells as in vitro models of non-alcoholic fatty liver disease.
    Khalil M; Khalifeh H; Baldini F; Salis A; Damonte G; Daher A; Voci A; Vergani L
    J Ethnopharmacol; 2019 Jul; 239():111919. PubMed ID: 31029756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicinal plants and phytochemicals with anti-obesogenic potentials: A review.
    Mopuri R; Islam MS
    Biomed Pharmacother; 2017 May; 89():1442-1452. PubMed ID: 28372259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Potential of Herbal Medicine against Non-alcoholic Fatty Liver Disease.
    Pourali G; Hosseini ZS; Maftooh M; Nazari E; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
    Curr Drug Targets; 2023; 24(4):300-319. PubMed ID: 36642873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions.
    Ore A; Akinloye OA
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Tricks for Old Guys: Recent Developments in the Chemistry, Biochemistry, Applications and Exploitation of Selected Species from the Lamiaceae Family.
    Napoli E; Siracusa L; Ruberto G
    Chem Biodivers; 2020 Mar; 17(3):e1900677. PubMed ID: 31967708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytochemicals for the treatment of metabolic diseases: Evidence from clinical studies.
    Luo Y; Zeng Y; Peng J; Zhang K; Wang L; Feng T; Nhamdriel T; Fan G
    Biomed Pharmacother; 2023 Sep; 165():115274. PubMed ID: 37542856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on wound healing effect of Mediterranean medicinal plants and some related phenolic compounds: A review.
    Mssillou I; Bakour M; Slighoua M; Laaroussi H; Saghrouchni H; Ez-Zahra Amrati F; Lyoussi B; Derwich E
    J Ethnopharmacol; 2022 Nov; 298():115663. PubMed ID: 36038091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal Plants of the Family Lamiaceae in Pain Therapy: A Review.
    Uritu CM; Mihai CT; Stanciu GD; Dodi G; Alexa-Stratulat T; Luca A; Leon-Constantin MM; Stefanescu R; Bild V; Melnic S; Tamba BI
    Pain Res Manag; 2018; 2018():7801543. PubMed ID: 29854039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial.
    Han K; Kwon O; Park HJ; Jung SY; Yang C; Son CG
    Trials; 2020 Jan; 21(1):128. PubMed ID: 32005283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.
    Koh YC; Lin YC; Lee PS; Lu TJ; Lin KY; Pan MH
    Food Funct; 2020 Sep; 11(9):7545-7560. PubMed ID: 32815965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice.
    Daniel T; Ben-Shachar M; Drori E; Hamad S; Permyakova A; Ben-Cnaan E; Tam J; Kerem Z; Rosenzweig T
    J Nutr Biochem; 2021 Dec; 98():108867. PubMed ID: 34571189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
    Naeini F; Namkhah Z; Tutunchi H; Rezayat SM; Mansouri S; Jazayeri-Tehrani SA; Yaseri M; Hosseinzadeh-Attar MJ
    Trials; 2021 Nov; 22(1):801. PubMed ID: 34774104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.